Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
St. Jude Children's Research Hospital
Ohio State University Comprehensive Cancer Center
Shanghai Pudong Hospital
Massachusetts General Hospital